Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CTMX
CTMX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CTMX News
CytomX Therapeutics Price Target Raised by Analysts
Mar 18 2026
stocktwits
CytomX Therapeutics Prices Public Offering
Mar 18 2026
Yahoo Finance
CytomX Launches $250 Million Public Offering
Mar 18 2026
seekingalpha
CytomX Announces Pricing of Public Offering
Mar 18 2026
NASDAQ.COM
CytomX Launches $250 Million Public Offering
Mar 17 2026
NASDAQ.COM
CytomX Launches $250 Million Stock Offering to Fund Cancer Drug Development
Mar 17 2026
stocktwits
CytomX Therapeutics Stock Surges 44.23% Following Positive Phase 1 Data
Mar 16 2026
Fool
CytomX Therapeutics Stock Soars 44.23% After Positive Phase 1 Data
Mar 16 2026
NASDAQ.COM
CytomX Therapeutics Stock Soars 44.23% After Positive Phase 1 Data
Mar 16 2026
Yahoo Finance
CytomX Launches $250 Million Underwritten Public Offering
Mar 16 2026
seekingalpha
CytomX Reports Significant Progress in Phase 1 Study of Varseta-M
Mar 16 2026
Yahoo Finance
CytomX Therapeutics Q4 2025 Earnings Call Insights
Mar 16 2026
seekingalpha
CytomX Reports Positive Clinical Data for Varseta-M and 2025 Financial Results
Mar 16 2026
NASDAQ.COM
NASDAQ 100 Pre-Market Indicator Rises Significantly
Mar 16 2026
NASDAQ.COM
CytomX Reports Promising Early Results for Varseta-M in Late-Line Metastatic Colorectal Cancer
Mar 16 2026
stocktwits
CytomX Reports Disappointing Earnings with Significant Revenue Decline
Mar 16 2026
seekingalpha
Show More News
